- Lorlatinib in Tyrosine Kinase Inhibitor−Naive Advanced ROS1 -Positive Non−Small Cell Lung Cancer
- Details Regarding Pneumonitis With High-Dose Aumolertinib—Reply
- Reduced-Dose Enfortumab Vedotin, Treatment Continuity, and Survival in Urothelial Cancer
- Unrelated Donor Age and Recipient Outcomes After Posttransplant Cyclophosphamide
- Clarifying End Point Definitions, Missingness, and Covariate Balance in the International TNT Study—Reply
- JAMA Oncology
- Metastatic Recurrence Among Adolescents and Young Adults With Cancer
- Clarifying End Point Definitions, Missingness, and Covariate Balance in the International TNT Study
- Disrupted Federal Funding for Extramural Cancer Research
- Metastatic Recurrence in Adolescent and Young Adult Cancer
- Radiotherapy Duality in Metastatic Disease
- Reshuffle
- Dual Immune Checkpoint Blockade in Microsatellite Instability-High Cancers
- Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer
- Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance
